z-logo
Premium
Characterization of a PRISTANE‐induced lupus‐associated model in the non‐human primate cynomolgus monkey
Author(s) -
Wang Jing,
Shen Hui,
Zhu Yuqiang,
Zhu Ying,
Cai Lei,
Wang Zhiyao,
Shi Qin,
Qiu Yuhua
Publication year - 2018
Publication title -
journal of medical primatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.31
H-Index - 42
eISSN - 1600-0684
pISSN - 0047-2565
DOI - 10.1111/jmp.12280
Subject(s) - systemic lupus erythematosus , primate , pristane , rheumatology , pathogenesis , medicine , immunology , lupus erythematosus , disease , non human primate , pathology , biology , antibody , neuroscience , chemistry , evolutionary biology , hydrocarbon , organic chemistry
Background Lupus is an autoimmune disease with complex syndrome. Rodent models have limitations for recapitulating the spectrum of the disease. A more powerful translational model is desirable. Method Lupus‐associated model in cynomolgus monkeys was induced by two intraperitoneal injections of 2, 6, 10, 14‐tetramethylpentadecane (PRISTANE). Lupus‐specific biomarkers and manifestations over a 246‐day period were observed at multilevel. To visualize and quantify kidney function in real time, contrast‐enhanced ultrasound was used. Results The indicative biomarkers and manifestations fulfilled major diagnosis criteria according to the “Criteria of Lupus” of the American College of Rheumatology. Significant changes in time‐intensity curve parameters were observed, indicating impaired renal function and the method as a feasible, non‐invasive diagnostic method in primate model. Conclusions We successfully induced lupus‐associated model with systemic lupus syndrome. This primate model can be a valuable translational model for further pathogenesis and symptomology studies and for exploring therapeutic candidates.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here